Active Filter(s):
Details:
The funding will be used to advance a first-of-its-kind RNA editing platform which enables multi-kilobase edits, allowing a single genetic medicine to treat diseases with high allelic diversity.
Lead Product(s): Genetic Medicine
Therapeutic Area: Genetic Disease Product Name: Undisclosed
Highest Development Status: Discovery Platform Product Type: Undisclosed
Partner/Sponsor/Collaborator: Playground Global
Deal Size: $26.0 million Upfront Cash: Undisclosed
Deal Type: Financing August 03, 2023